跳至主要内容
临床试验/NCT01025102
NCT01025102已完成3 期

Phase III Study of the Addition of Sufentanil to Interscalene Block in Shoulder Surgery

Bent Gymoese Jorgensen1 个研究点 分布在 1 个国家目标入组 26 人开始时间: 2010年1月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
26
试验地点
1
主要终点
Time to experience of moderate to severe postoperative pain

研究概览

简要总结

The purpose of this study is to compare the effects and side effects of interscale block performed with Naropin 0.1% cum sufentanil or Naropin 0.1% in shoulder surgery.

详细描述

The purpose of this study is to compare the duration of postoperative analgesia and supplemental opioid consumption and side effects of interscale block performed with Naropin 0.1% cum sufentanil or Naropin 0.1% in shoulder surgery

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • ASA I-III
  • Age 18-80
  • Shoulder surgery performed under interscalene block and general anesthesia

排除标准

  • Contraindication of interscalene block
  • Severe chronic obstructive lung disease
  • Non-cooperative patient
  • Intolerance to opioids
  • Pregnancy
  • Rheumatoid arthritis and diabetes with peripheral polyneuropathy
  • Chronic pain or daily opioid intake

研究组 & 干预措施

Naropin 0.1%

Experimental

干预措施: Naropin 0.1% cum sufentanil (Drug)

结局指标

主要结局

Time to experience of moderate to severe postoperative pain

时间窗: On day of surgery and 1., 2. and 3. postop. day

次要结局

  • Side effects(On day of surgery and 1., 2. and. 3. postop. day)

研究者

发起方
Bent Gymoese Jorgensen
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Bent Gymoese Jorgensen

MD

Frederiksberg University Hospital

研究点 (1)

Loading locations...

相似试验

The Addition of Sufentanil Interscalene Block in... | 临床试验